Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vor Biopharma Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 1 filing
- 1 insider, $4.21K in total
- Insiders trading
- 1
- Net value
- −$4.21K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vor Biopharma Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| RA Capital Healthcare Fund LP | 10% Owner | 1,500Indirect | Aug 26, 2026 | 13 |
| Ra Capital Management, L.P. | 10% Owner | 1,500Indirect | Aug 26, 2026 | 13 |
| Kolchinsky Peter | 10% Owner | 1,500Indirect | Aug 26, 2026 | 13 |
| Shah Rajeev M. | 10% Owner | 1,500Indirect | Aug 26, 2026 | 13 |
| Zaccardelli David | Director | – | Jul 9, 2026 | 1 |
| Kalir Erez | Director | – | Jun 12, 2026 | 1 |
| Beckman Daniella | Director | – | Jun 12, 2026 | 1 |
| Cumbo Alexander | Director | – | Jun 12, 2026 | 1 |
| Namouni Fouad | Director | – | Jun 12, 2026 | 1 |
| Detheux Michel | Director | – | Jun 12, 2026 | 1 |
| Levin Andrew David | Director | – | Jun 12, 2026 | 2 |
| Joustra Wouter | Director | – | Jun 12, 2026 | 2 |
| Mahatme Sandesh | CFO | 0 | Dec 9, 2025 | 1 |
| Kress Jean-Paul | CEO and Chairman | – | Dec 9, 2025 | 1 |
| Zuraw Qing Che | Chief Development Officer | 937,080 | Dec 9, 2025 | 1 |
| RA Capital Nexus Fund, L.P. | Director | 1,401,226Indirect | Oct 22, 2025 | 2 |
| Hoffman Reid | 10% Owner | 1,166,909 | Oct 21, 2025 | 6 |
| Reprogrammed Interchange LLC | 10% Owner | 1,166,909 | Oct 21, 2025 | 6 |
| Reed Sarah Burgess | Director | – | Sep 10, 2025 | 0 |
| Patterson Matthew R | Director | – | May 23, 2025 | 0 |
| Lubner David Charles | Director | – | May 23, 2025 | 0 |
| Lundberg Sven Ante | Director | – | May 23, 2025 | 0 |
| Resnick Joshua | Director | – | May 23, 2025 | 0 |
| Ang Robert | PRESIDENT AND CEO | 911,318 | May 7, 2025 | 0 |
| Chakraborty Tirtha | Chief Sci Off & Head Tech Ops | 217,416 | May 7, 2025 | 0 |
| Choi Han Wook | Chief Financial Officer | 51,280 | May 2, 2025 | 0 |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | 126,625 | Feb 18, 2025 | 0 |
| Quinlan Amy | Vice President of Finance | 50,312 | Nov 8, 2024 | 0 |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | 189,403 | May 7, 2024 | 0 |
| Parmar Kush | Director, 10% Owner | 1,766,634Indirect | Jun 16, 2022 | 0 |
| Slapak Christopher | Chief Medical Officer | – | Feb 3, 2022 | 0 |
| Schwab Andrew J. | 10% Owner | 1,766,634Indirect | Nov 18, 2021 | 0 |
| 5AM Opportunities I, L.P. | 10% Owner | 1,766,634Indirect | Nov 18, 2021 | 0 |
| 5AM Ventures VI, L.P. | 10% Owner | 1,766,634Indirect | Nov 18, 2021 | 0 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 1,766,634Indirect | Nov 18, 2021 | 0 |
| 5AM Partners VI, LLC | 10% Owner | 1,766,634Indirect | Nov 18, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Parmar KushDirector, 10% Owner | SSale | −330.7K | $15.30 | −$5.06M | −15.8%1.77M after | 2 lots |
| Nov 18, 2021 (view filing)8:14 PM ET | Nov 16 | 2 days | Schwab Andrew J. and 4 others10% Owner | SSale | −330.7K | $15.30 | −$5.06M | −15.8%1.77M after | 2 lotsDuplicate filing |
| Jun 4, 2024 (view filing) | Jun 3 | 1 day | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −14.6K | $1.39 | −$20.4K | −13.2%96.1K after | 10b5-1 |
| Dec 31, 2024 (view filing) | Dec 27 | 4 days | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −10.3K | $1.25 | −$12.9K | −11.3%81.4K after | 10b5-1 |
| Jan 2, 2025 (view filing)7:42 PM ET | Dec 30, 2024 | 3 days | Hoffman Reid and 1 other10% Owner | PPurchase | +39.0M | – | – | New position39.0M after | |
| Jan 2, 2025 (view filing)7:42 PM ET | Dec 30, 2024 | 3 days | Hoffman Reid and 1 other10% Owner | PPurchase | +48.7M | – | – | –48.7M after | Derivative |
| Feb 12, 2025 (view filing) | Feb 10 | 2 days | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −2.55K | $1.37 | −$3.50K | −1.9%128.9K after | 10b5-1 |
| Feb 18, 2025 (view filing) | Feb 13 | 5 days | Attar Eyal C.CHIEF MEDICAL OFFICER | SSale | −2.23K | $1.42 | −$3.16K | −1.7%126.6K after | 10b5-1 |
| Aug 27, 2025 (view filing)5:25 PM ET | Aug 25-26 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −671.5K | $2.10 | −$1.41M | −1.7%38.3M after | 2 lots |
| Aug 29, 2025 (view filing)6:05 PM ET | Aug 27-28 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −1.42M | $2.01 | −$2.85M | −3.7%36.9M after | 2 lots |
| Sep 5, 2025 (view filing)6:51 PM ET | Sep 3-5 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −1.41M | $1.97 | −$2.77M | −3.8%35.5M after | 3 lots |
| Sep 10, 2025 (view filing)8:27 PM ET | Sep 8-10 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −1.26M | $1.95 | −$2.46M | −3.6%34.2M after | 3 lots |
| Sep 15, 2025 (view filing)5:17 PM ET | Sep 11-15 | 4 days | Hoffman Reid and 1 other10% Owner | SSale | −984.8K | $1.73 | −$1.70M | −2.9%33.2M after | 3 lots |
| Sep 18, 2025 (view filing)8:40 PM ET | Sep 16 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −447.3K | $1.54 | −$688.9K | −1.3%32.8M after | |
| Oct 3, 2025 (view filing)9:12 PM ET | Oct 1-3 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −41.8K | $39.43 | −$1.65M | −2.5%1.60M after | 8 lots |
| Oct 8, 2025 (view filing)5:20 PM ET | Oct 6-7 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −98.4K | $36.12 | −$3.55M | −6.2%1.50M after | 4 lots |
| Oct 10, 2025 (view filing)5:51 PM ET | Oct 8-9 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −124.1K | $33.16 | −$4.12M | −8.3%1.37M after | 4 lots |
| Oct 15, 2025 (view filing)6:32 PM ET | Oct 10-14 | 5 days | Hoffman Reid and 1 other10% Owner | SSale | −96.7K | $31.08 | −$3.00M | −7.0%1.28M after | 4 lots |
| Oct 17, 2025 (view filing)6:03 PM ET | Oct 15-17 | 2 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | SSale | −464.0K | $29.54 | −$13.7M | −96.8%15.1K after | 16 lots |
| Oct 17, 2025 (view filing)6:33 PM ET | Oct 15-16 | 2 days | Hoffman Reid and 1 other10% Owner | SSale | −73.7K | $31.88 | −$2.35M | −5.8%1.20M after | 4 lots |
| Oct 21, 2025 (view filing)5:45 PM ET | Oct 17-21 | 4 days | Hoffman Reid and 1 other10% Owner | SSale | −37.5K | $30.19 | −$1.13M | −3.1%1.17M after | 4 lots |
| Oct 22, 2025 (view filing)7:48 PM ET | Oct 20-21 | 2 days | RA Capital Healthcare Fund LP and 4 othersDirector, 10% Owner | SSale | −117.0K | $29.34 | −$3.43M | −7.7%1.40M after | 5 lots |
| Oct 27, 2025 (view filing)8:04 PM ET | Oct 23-27 | 4 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −221.2K | $28.06 | −$6.20M | −15.8%1.18M after | 3 lots |
| Oct 30, 2025 (view filing)6:40 PM ET | Oct 28-30 | 2 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −400.4K | $25.90 | −$10.4M | −33.9%779.7K after | 4 lots |
| Apr 6, 2026 (view filing)6:51 PM ET | Apr 2-6 | 4 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −849.3K | $17.10 | −$14.5M | −15.7%4.56M after | 5 lots |
| Apr 10, 2026 (view filing)6:23 PM ET | Apr 8-10 | 2 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −620.1K | $16.50 | −$10.2M | −13.6%3.94M after | 4 lots |
| Apr 15, 2026 (view filing)5:29 PM ET | Apr 13-15 | 2 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −738.0K | $16.10 | −$11.9M | −18.8%3.20M after | 3 lots |
| Apr 21, 2026 (view filing)7:04 PM ET | Apr 17-20 | 4 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −630.4K | $16.14 | −$10.2M | −19.7%2.57M after | 2 lots |
| Apr 24, 2026 (view filing)6:12 PM ET | Apr 22 | 2 days | RA Capital Healthcare Fund LP and 3 othersDirector, 10% Owner | SSale | −165.2K | $15.77 | −$2.60M | −6.4%2.40M after | |
| Jul 21, 2026 (view filing)4:54 PM ET | Jul 16 | 5 daysLate | RA Capital Healthcare Fund LP and 3 others10% Owner | SSale | −213 | $19.75 | −$4.21K | 0.0%4.50M after |